-
1 Comment
Demant A/S is currently in a long term uptrend where the price is trading 41.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
Finally, its free cash flow grew by 48.0% to $816M since the same quarter in the previous year.
Based on the above factors, Demant A/S gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | DK0060738599 |
Sector | Healthcare |
Industry | Medical Devices |
PE Ratio | 18.57 |
---|---|
Target Price | None |
Beta | 0.91 |
Market Cap | 7B |
Dividend Yield | None |
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids and personalized hearing care products, as well as offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for WDH1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025